Skip to main content
  • Original article
  • Open access
  • Published:

Burden of bacterial exacerbation in bronchial asthma in Assiut University Hospitals, Egypt

Abstract

Background

Asthma is one of the most common chronic respiratory diseases. Despite advances in asthma management, acute exacerbations continue to occur and impose considerable morbidity and mortality on patients and constitute a major burden on healthcare resources.

Objective

This study aimed to determine the associations between bacterial infections and adult asthma exacerbations, together with detection of antibiotic resistance patterns in clinical practice.

Patients and methods

Sputa were collected from 60 adult asthmatic patients recruited from both Internal Medicine Department and Chest Disease Department and their critical care units during exacerbation attacks. Patients underwent thorough clinical examination, laboratory investigations, and pulmonary function tests. Bacterial isolates were identified using the standard diagnostic methods. Susceptibilities of the isolated bacterial strains were determined using disk diffusion method.

Results

Significant bacterial growth was detected in 47 (78%) patients. Single etiological agent was detected among 44 (73%) patients, whereas mixed infection was found in three (5%) patients. A total of 52 bacterial strains were isolated from our asthmatic patients. The predominant bacterial strains were as follows in decreasing order: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Klebsiella pneumoniae, Staphylococcus aureus, Acinetobacter baumannii, and Pseudomonas aeruginosa. Gram-negative bacilli constituted 52% (27 isolates) of the total bacterial isolates during the exacerbation attacks. Non-multidrug-resistant bacteria were 15 (30%) in number, 22 (44%) bacterial isolates were multidrug resistant, six (12%) bacterial isolates were extensively drug resistant, and seven (14%) isolates were pandrug resistant.

Conclusion

Acute exacerbation of asthma was associated with infection in most patients. Gram-negative bacteria and S. pneumoniae form a relevant part of the microbial pattern of exacerbation of asthma. Antibiotic resistance among bacterial strains remains a challenge for the management of asthma exacerbations in clinical settings.

References

  1. Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011; 128:1165–1174.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al. Disordered microbial communities in asthmatic airways. PLoS One 2010; 5:e8578.

  3. Kraft M. The role of bacterial infections in asthma. Clin Chest Med 2000; 21:301–313.

    Article  CAS  PubMed  Google Scholar 

  4. Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, Saito H, et al. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. Blood 2003; 102:2547–2554.

    Article  CAS  PubMed  Google Scholar 

  5. Drake MG, Kaufman EH, Fryer AD, Jacoby DB. The therapeutic potential of toll-like receptor 7 stimulation in asthma. Inflamm Allergy Drug Targets 2012; 11:484–491.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Iikura M, Hojo M, Koketsu R, Watanabe S, Sato A, Chino H, et al. The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice. PLoS One 2015; 10:e0123584.

  7. Aldington S, Beasley R. Asthma exacerbations 5: assessment and management of severe asthma in adults in hospital. Thorax 2007; 62:447–458.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Indrayan AD, Kumar RM, Dwivedi SD. A simple index of smoking. COBRA Preprint Series 2008 :40.

  9. Carroll JD, Hess OM. Assessment of normal and abnormal cardiac function. In: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald’s heart disease: a text book of cardiovascular medicine. Vol. 2. 7th ed. Philadelphia, PA: Elsevier Saunders; 2005: p. 498.

  10. Institute CaLS. M100-S22: performance standards for antimicrobial susceptibility testing; twenty-two informational supplement. Wayne, PA: Institute CaLS; 2012.

  11. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268–281.

    Article  CAS  PubMed  Google Scholar 

  12. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 2007; 18:CD000195.

  13. Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet 2014; 384:691–702.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Allegra L, Blasi F, Centanni S, Cosentini R, Denti F, Raccanelli R, et al. Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur Respir J 1994; 7:2165–2168.

    Article  CAS  PubMed  Google Scholar 

  15. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bonnelykke K, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487–1495.

    Article  CAS  PubMed  Google Scholar 

  16. Green BJ, Wiriyachaiporn S, Grainge C, Rogers GB, Kehagia V, Lau L, et al. Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma. PLoS One 2014; 9:e100645.

  17. Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, HallCF, et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 2013; 188:1193–1201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011; 127: 372–381; e1-e3.

  19. Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol 2013; 131:346–352; e1-e3.

  20. Eder W, Ege M, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355:2226–2235.

    Article  CAS  PubMed  Google Scholar 

  21. Thomson NC, Chaudhuri R, Livingston E. Active cigarette smoking and asthma. Clin Exp Allergy 2003; 33:1471–1475.

    Article  CAS  PubMed  Google Scholar 

  22. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004; 24:822–833.

    Article  CAS  PubMed  Google Scholar 

  23. Hunter MH, King DE. COPD: management of acute exacerbations and chronic stable disease. Am Fam Physician 2001; 64:603–612.

    CAS  PubMed  Google Scholar 

  24. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168:1308–1311.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soheir M. K. Ahmed.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed, S.M.K., Embarek Mohamed, M.S.E. & Hassan, A.T. Burden of bacterial exacerbation in bronchial asthma in Assiut University Hospitals, Egypt. Egypt J Intern Med 29, 71–76 (2017). https://doi.org/10.4103/ejim.ejim_20_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_20_17

Keywords